BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3607)

  • 1. IgM-mediated, T cell-independent suppression of humoral immunity.
    Ordal J; Smith S; Ness D; Gershon RK; Grumet FC
    J Immunol; 1976 Apr; 116(4):1182-7. PubMed ID: 3607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of antibody responses in allogeneic mice by products of lymphoid tissue. I. Allogeneic suppressive factor (ASF) from spleens repopulated with thymus cells.
    Yonkosky D; Buffett RF; Bennett M
    J Immunol; 1976 Jun; 116(6):1688-94. PubMed ID: 58046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoid cell dependence of eosinophil response to antigen. VI. The effect of selective removal of T or B lymphocytes on the capacity of primed spleen cells to adoptively transferred immunity to tetanus toxoid.
    Ponzio NM; Speirs RS
    Immunology; 1975 Feb; 28(2):243-51. PubMed ID: 1079015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune dysfunction associated with graft-vs-host reaction in mice transplanted across minor histocompatibility barriers. II. Reversible defect in T-dependent antibody responses.
    Budhecha S; Hamilton BL
    J Immunol; 1989 Jun; 142(11):3740-5. PubMed ID: 2523932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of antibody responses in allogeneic mice by products of lymphoid tissue. II. Lack of antigenic specificity and immunogenetic requirements of allogeneic suppressive factor (ASF).
    Yonkosky D; Buffett RF; Bennett M
    J Immunol; 1976 Jun; 116(6):1695-703. PubMed ID: 58047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific, transient suppression of the immune response by HGG tolerant spleen cells. II. Effector cells and target cells.
    Doyle MV; Parks E; Weigle WO
    J Immunol; 1976 Oct; 117(4):1152-8. PubMed ID: 61992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mls-1a-induced peripheral tolerance to host minor histocompatibility antigens in radiation bone marrow chimeras. Modification of T cell repertoire associated with active suppression and permanent presentation of host antigens.
    Miconnet I; Bruley-Rosset M; Halle-Pannenko O
    J Immunol; 1992 Jun; 148(12):3706-13. PubMed ID: 1534822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of specific helper cells and suppressor cells in vitro for the IgE and IgG antibody responses.
    Ishizaka K; Adachi T
    J Immunol; 1976 Jul; 117(1):40-7. PubMed ID: 1084370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells.
    Lamon EW; Whitten HD; Skurzak HM; Andersson B; Lidin B
    J Immunol; 1975 Nov; 115(5):1288-94. PubMed ID: 1080777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenic properties of modified antigen E. II. Ability of urea-denatured antigen and alpha-polypeptide chain to prime T cells specific for antigen E.
    Ishizaka K; Okudaira H; King TP
    J Immunol; 1975 Jan; 114(1 Pt 1):110-5. PubMed ID: 803524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfer of immunity by transfer of bone marrow cells: a requirement for T lymphocytes and sensitivity to cyclophosphamide.
    Marusić M
    Exp Hematol; 1978 Oct; 6(9):725-37. PubMed ID: 361429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary IgG responses to type III pneumococcal polysaccharide. II. Different cellular requirements for induction and elicitation.
    Braley-Mullen H
    J Immunol; 1976 Apr; 116(4):904-10. PubMed ID: 3609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of graft-versus-host reaction on the immune response to alloantigens and growth of a syngeneic tumor.
    Zaleski M
    Exp Hematol; 1975 Jan; 3(1):12-21. PubMed ID: 238866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of IFN-gamma and transforming growth factor-beta in graft-vs-host reaction-associated immunosuppression.
    Huchet R; Bruley-Rosset M; Mathiot C; Grandjon D; Halle-Pannenko O
    J Immunol; 1993 Mar; 150(6):2517-24. PubMed ID: 8450227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of antigenic potency in vitro and immunogenicity in vivo by coupling the antigen to anti-immunoglobulin.
    Kawamura H; Berzofsky JA
    J Immunol; 1986 Jan; 136(1):58-65. PubMed ID: 3079611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of cytotoxic T lymphocytes in vitro. VII. Suppressive effect of irradiated MLC cells on CTL response.
    Fitch FW; Engers HD; Cerottini JC; Bruner KT
    J Immunol; 1976 Mar; 116(3):716-23. PubMed ID: 56399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reaginic antibody formation in the mouse. VII. Induction of suppressor T cells for IgE and IgG antibody responses.
    Takatsu K; Ishizaka K
    J Immunol; 1976 May; 116(5):1257-64. PubMed ID: 1083868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular cooperation during in vivo anti-hapten antibody responses. III. The helper cell activity of activated thymocytes, of spleen cells treated with anti-theta serum, and of spleen cells from anti-thymocyte serum-treated or adult thymectomized donors.
    Janeway CA
    J Immunol; 1975 Apr; 114(4):1408-14. PubMed ID: 1078836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell-dependent helper and suppressive influences in an adoptive IgG antibody response.
    Arrenbrecht S; Mitchell GF
    Immunology; 1975 Mar; 28(3):485-95. PubMed ID: 1092611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous leishmaniasis in anti-IgM-treated mice: enhanced resistance due to functional depletion of a B cell-dependent T cell involved in the suppressor pathway.
    Sacks DL; Scott PA; Asofsky R; Sher FA
    J Immunol; 1984 Apr; 132(4):2072-7. PubMed ID: 6230400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.